chr7-83961625-T-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_006080.3(SEMA3A):āc.2062A>Gā(p.Thr688Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000156 in 1,614,040 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_006080.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SEMA3A | NM_006080.3 | c.2062A>G | p.Thr688Ala | missense_variant | 17/17 | ENST00000265362.9 | NP_006071.1 | |
SEMA3A | XM_005250110.4 | c.2062A>G | p.Thr688Ala | missense_variant | 20/20 | XP_005250167.1 | ||
SEMA3A | XM_047419751.1 | c.2062A>G | p.Thr688Ala | missense_variant | 21/21 | XP_047275707.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SEMA3A | ENST00000265362.9 | c.2062A>G | p.Thr688Ala | missense_variant | 17/17 | 1 | NM_006080.3 | ENSP00000265362.3 | ||
SEMA3A | ENST00000436949.5 | c.2062A>G | p.Thr688Ala | missense_variant | 18/18 | 5 | ENSP00000415260.1 |
Frequencies
GnomAD3 genomes AF: 0.000164 AC: 25AN: 152150Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000183 AC: 46AN: 251298Hom.: 1 AF XY: 0.000272 AC XY: 37AN XY: 135822
GnomAD4 exome AF: 0.000155 AC: 226AN: 1461772Hom.: 1 Cov.: 33 AF XY: 0.000180 AC XY: 131AN XY: 727180
GnomAD4 genome AF: 0.000164 AC: 25AN: 152268Hom.: 0 Cov.: 32 AF XY: 0.000161 AC XY: 12AN XY: 74444
ClinVar
Submissions by phenotype
not provided Uncertain:2Other:1
not provided, no classification provided | literature only | UniProtKB/Swiss-Prot | - | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 07, 2024 | This sequence change replaces threonine, which is neutral and polar, with alanine, which is neutral and non-polar, at codon 688 of the SEMA3A protein (p.Thr688Ala). This variant is present in population databases (rs318240751, gnomAD 0.09%). This missense change has been observed in individual(s) with Kallmann syndrome (PMID: 22927827). ClinVar contains an entry for this variant (Variation ID: 68833). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The alanine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. Experimental studies have shown that this missense change affects SEMA3A function (PMID: 22927827). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Nov 11, 2014 | - - |
Hypogonadotropic hypogonadism 16 with or without anosmia Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
SEMA3A-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 24, 2024 | The SEMA3A c.2062A>G variant is predicted to result in the amino acid substitution p.Thr688Ala. This variant has been reported in the heterozygous state in an individual with Kallmann syndrome (Hanchate et al. 2012. PubMed ID: 22927827) and an individual with CHARGE Syndrome (Schulz et al. 2014. PubMed ID: 24728844). The individual with Kallmann syndrome also harbored an additional variant in another gene (Hanchate et al. 2012. PubMed ID: 22927827). In vitro functional studies suggest that this variant reduces the signaling activity of the encoded protein (Hanchate et al. 2012. PubMed ID: 22927827). It is reported in 0.091% of alleles in individuals of South Asian descent in gnomAD, including one homozygous finding, which may be too frequent to be a primary cause of disease. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at